BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 36016324)

  • 1. Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia.
    Panagiota V; Dobbelstein C; Werwitzke S; Ganser A; Cooper N; Sachs UJ; Tiede A
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
    Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
    JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
    Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
    Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
    Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
    Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-Onset Vaccine-Induced Immune Thombotic Thrombocytopenia (VITT) with Cerebral Venous Sinus Thrombosis.
    Saleh M; Zimmermann J; Lehnen NC; Pötzsch B; Weller JM
    J Stroke Cerebrovasc Dis; 2022 Apr; 31(4):106311. PubMed ID: 35093626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.
    Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A
    J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke.
    Kenda J; Lovrič D; Škerget M; Milivojević N
    J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106072. PubMed ID: 34461442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
    Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
    Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncommon thrombotic complications after SARS-CoV-2 vaccination.
    Musil D
    Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase.
    van de Munckhof A; Lindgren E; Kleinig TJ; Field TS; Cordonnier C; Krzywicka K; Poli S; Sánchez van Kammen M; Borhani-Haghighi A; Lemmens R; Scutelnic A; Ciccone A; Gattringer T; Wittstock M; Dizonno V; Devroye A; Elkady A; Günther A; Cervera A; Mengel A; Chew BLA; Buck B; Zanferrari C; Garcia-Esperon C; Jacobi C; Soriano C; Michalski D; Zamani Z; Blacquiere D; Johansson E; Cuadrado-Godia E; Vuillier F; Bode FJ; Caparros F; Maier F; Tsivgoulis G; Katzberg HD; Duan J; Burrow J; Pelz J; Mbroh J; Oen J; Schouten J; Zimmermann J; Ng K; Garambois K; Petruzzellis M; Carvalho Dias M; Ghiasian M; Romoli M; Miranda M; Wronski M; Skjelland M; Almasi-Dooghaee M; Cuisenier P; Murphy S; Timsit S; Coutts SB; Schönenberger S; Nagel S; Hiltunen S; Chatterton S; Cox T; Bartsch T; Shaygannejad V; Mirzaasgari Z; Middeldorp S; Levi MM; Kremer Hovinga JA; Jood K; Tatlisumak T; Putaala J; Heldner MR; Arnold M; Aguiar de Sousa D; Ferro JM; Coutinho JM;
    Stroke; 2022 Oct; 53(10):3206-3210. PubMed ID: 36082668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombotic immune thrombocytopenia after COVID-19 vaccination.
    Tiede A; Sachs UJ; Czwalinna A; Werwitzke S; Bikker R; Krauss JK; Donnerstag F; Weißenborn K; Höglinger G; Maasoumy B; Wedemeyer H; Ganser A
    Blood; 2021 Jul; 138(4):350-353. PubMed ID: 34323939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis.
    Schönborn L; Seck SE; Thiele T; Kaderali L; Hoffmann T; Hlinka A; Lindhoff-Last E; Völker U; Selleng K; Buoninfante A; Cavaleri M; Greinacher A
    J Thromb Haemost; 2023 Sep; 21(9):2519-2527. PubMed ID: 37394120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding vaccine-induced thrombotic thrombocytopenia (VITT).
    Dix C; McFadyen J; Huang A; Chunilal S; Chen V; Tran H
    Intern Med J; 2022 May; 52(5):717-723. PubMed ID: 35446471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.
    Lai CC; Ko WC; Chen CJ; Chen PY; Huang YC; Lee PI; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1027-1035. PubMed ID: 34176415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic thrombosis and acute limb ischemia after ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccination: a case of vaccine-induced thrombocytopenia and thrombosis (VITT).
    Vierstraete M; Sabbe T
    Acta Chir Belg; 2023 Jun; 123(3):329-332. PubMed ID: 34890294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.
    Rodriguez EVC; Bouazza FZ; Dauby N; Mullier F; d'Otreppe S; Jissendi Tchofo P; Bartiaux M; Sirjacques C; Roman A; Hermans C; Cliquennois M
    Infection; 2022 Apr; 50(2):531-536. PubMed ID: 34626338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.
    Favaloro EJ
    Int J Lab Hematol; 2021 Aug; 43(4):559-570. PubMed ID: 34138513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Aspects of VITT.
    Schönborn L; Greinacher A
    Semin Hematol; 2022 Apr; 59(2):108-114. PubMed ID: 35512899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia.
    Huynh A; Arnold DM; Ivetic N; Clare R; Hadzi-Tosev M; Liu Y; Smith JW; Bissola AL; Daka M; Kelton JG; Nazy I
    J Thromb Haemost; 2023 Oct; 21(10):2833-2843. PubMed ID: 37394121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebral Hemorrhage due to Thrombosis with Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in Korea.
    Choi JK; Kim S; Kim SR; Jin JY; Choi SW; Kim H; Yoo JH; Park IS; Kim SR
    J Korean Med Sci; 2021 Aug; 36(31):e223. PubMed ID: 34402235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.